Login / Signup

Concerns regarding the methodology, reporting and interpretation of the therapeutic plasma exchange in multiple sclerosis randomized sham-controlled (PLASMASEP) trial.

Jamal H Carter
Published in: Journal of clinical apheresis (2021)
Keyphrases
  • phase iii
  • double blind
  • multiple sclerosis
  • phase ii
  • placebo controlled
  • clinical trial
  • open label
  • study protocol
  • adverse drug
  • white matter
  • randomized controlled trial